glp-1 agonists drugs Comparing Ozempic, Wegovy and Other Cardiovascular and mortality outcomes with

[DOI] [PMC free article] [PubMed] [Google Scholar] 132.Vaduganathan M, Filippatos G, Claggett BL, Desai AS, Jhund PS, Henderson A, et al

doi: 10.2337/db13-1440

Effects of glucagon-like peptide-1 receptor agonists on gut microbiota in dehydroepiandrosterone-induced polycystic ovary syndrome mice: compared evaluation of liraglutide and semaglutide intervention

Night sweats, early waking, fragmented sleep, and slower muscle recovery all pile on in a way that mimics medication side effects

With favorable results, it might become a first-in-class fixed-dose injectable therapy for both obesity and T2DM

For anyone exploring GLP-1s for weight loss, the first surprise often comes with the price tag